According to Poonawalla, Serum can never go off for sale but could merge with Cipla which will give a big synergy to both the companies.
CNBC-TV18'S Shereen Bhan caught up with Cyrus Poonawalla, Chairman, Poonawalla Group and asked him about Serum being in exploratory talks with Cipla for possible merger.
According to Poonawalla, Serum can never go off for sale but could merge with Cipla which will give a big synergy to both the companies.
The group has joined hands with Cipla to launch its products in Europe and regulated markets where they are stronger because of their experience in marketing strengths.
Poonawalla also said that Serum is in initial talks with Cipla but that is just the beginning. "We have to first see how our initial partnership bears fruit. If it moves a right direction then may be we will take in to the next stage," he added.
Cipla stock price
On February 06, 2015, at 14:10 hrs Cipla was quoting at Rs 675.40, up Rs 13.45, or 2.03 percent. The 52-week high of the share was Rs 711.45 and the 52-week low was Rs 366.70.
The company's trailing 12-month (TTM) EPS was at Rs 15.02 per share as per the quarter ended September 2014. The stock's price-to-earnings (P/E) ratio was 44.97. The latest book value of the company is Rs 125.68 per share. At current value, the price-to-book value of the company is 5.37.
Anda sedang membaca artikel tentang
Will launch products in Europe with Cipla: Poonawalla
Dengan url
https://kesehatanda.blogspot.com/2015/02/will-launch-products-in-europe-with.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Will launch products in Europe with Cipla: Poonawalla
namun jangan lupa untuk meletakkan link
Will launch products in Europe with Cipla: Poonawalla
sebagai sumbernya
0 komentar:
Posting Komentar